Healthtech Startups

Interleukin operates a B2B platform for sourcing and procuring medical products and services, letting registered buyers discover accredited suppliers, request quotes, send purchase orders, and pay on terms in one system. It targets medical institution buyers and distributors/suppliers in the Philippines.

1 investor

1 investor

Interpace Biosciences provides molecular diagnostic tests for the early diagnosis and treatment of cancer, with a focus on risk-stratifying indeterminate thyroid nodules through genetic and mutational analysis. The company serves specialty physicians and medical centers in the U.S. and internationally.

1 investor

1 investor

Intershunt develops the Dynama System (also known as the PAS-C System), an investigational interatrial shunting device designed to create a pathway in the heart's upper chambers to reduce elevated left atrial pressure and relieve heart failure symptoms. It targets select heart failure patients with reduced ejection fraction and is being evaluated in the EASE HF2 early feasibility clinical study.

1 investor

Intervacc develops veterinary vaccines based on recombinant protein fusions. The company's lead product, Strangvac®, prevents strangles in horses, a serious and contagious global disease, and is available on several major European markets.

1 investor

1 investor

Interwell Health provides value-based kidney care, partnering with health plans, payers, and nephrology practices to support patients through nurses and dietitians and improve patient outcomes. It works to lower total cost of care and offers educational resources for patients and industry insights for providers and payers.

1 investor

Intonate offers an AI-powered medical documentation tool that converts consultations, dictations, and documents into structured reports and patient records, integrating directly with practice and clinic management software. It serves doctors, medical practices, and clinics, with a focus on compliance with Swiss and European data protection laws.

1 investor

Intragel is developing SRGel, a solvent-free long-acting injectable (LAI) drug delivery platform designed to enable controlled, extended release from a single injection for small molecules, peptides and biologics. The platform aims to extend dosing intervals and reduce injection frequency across multiple therapeutic areas.

1 investor

Intracare Health Services is a licensed, insured, and nationally accredited health services provider. This page is a careers/recruitment page inviting professionals to apply to join the team.

1 investor

A biopharmaceutical company developing treatments for psychiatric and neurologic disorders based on research into how therapies affect cellular mechanisms. The company, now part of Johnson & Johnson, focuses on innovative therapies for patients with complex brain-related diseases.

1 investor

IntraOp develops the Mobetron, a compact and mobile linear accelerator for electron therapy used to treat cancer, including intraoperative radiotherapy (IORT), non-invasive skin cancer treatment, and ultra-high dose rate (UHDR) FLASH research. Its systems are used by oncologists, hospitals, and research centers to deliver radiation therapy at the point of care.

1 investor

IntraPosition develops a real-time location system for hospitals using ultra-wideband technology to optimize bed management, patient flow, asset tracking, and staff communication. The solution serves healthcare operations teams managing facilities more cost-effectively than legacy positioning systems.

1 investor

Intressa Vascular develops the Allay Aortic Stent using proprietary multilayer braiding technology and personalized procedure planning to treat aortic dissections in patients requiring endovascular intervention.

1 investor

IntuiTap Medical makes VerTouch+, an FDA-cleared handheld imaging device that generates a real-time 2D map (TactoMap) of lumbar anatomy to guide bedside needle placement for neuraxial procedures such as spinal punctures. It is used by clinicians including physicians, PAs, and CRNAs to improve accuracy and consistency of spinal procedures while reducing reliance on radiology.

1 investor

Intuitive develops robotic-assisted surgical systems, including the da Vinci systems for minimally invasive surgery and the Ion system for bronchoscopy. Its products are medical devices used by surgeons and physicians in healthcare settings.

1 investor

Inuneko Seikatsu manufactures and sells pet food and nutritional supplements for dogs and cats, alongside veterinary and grooming services, with a mission to reduce euthanasia of stray animals in Japan. The company operates shelters nationwide and offers preventive healthcare services through its veterinary clinics.

1 investor

A shared resource dedicated to the care economy, providing guides and advisory information for entrepreneurs, corporate leaders, and investors in the sector.

1 investor

Invisalert Solutions provides a patient safety platform using machine learning and AI to monitor and prevent adverse events such as falls, infections, and elopement across acute care, emergency departments, behavioral health, and long-term care facilities. The software delivers real-time alerts and compliance documentation for over 500 healthcare organizations.

1 investor

InvisiShield Technologies develops products designed to prevent respiratory infections from airborne viruses such as COVID-19, influenza, and RSV. The company focuses on protecting people from illnesses caused by respiratory viruses.

1 investor

InVita Health provides software platforms for blood banks and organ transplantation centers to manage donations and medical device inventories. The company serves U.S. blood providers and deceased organ donation programs.

1 investor

Invitrall develops long-lasting, disease-representative human skin organoids from reprogrammed human cells, combining cell reprogramming, organoids, and machine learning to create human preclinical models. Its platform supports efficacy and repeated-dose toxicity testing for pharmaceutical and dermocosmetics companies developing skin drugs and cosmetics, as an alternative to animal testing.

1 investor

Invitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.

1 investor